Frazier Life Sciences VIII, L.P.
10% owner at Arcutis Biotherapeutics.
- Rank
- 422nd of 813
- Companies held
- 1
- Largest holding
- ARQT, 100.0% of total
- Latest SEC filing
- Oct 24, 2023
- Listed but not counted
- $190
What the $240M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics ARQT Common Stock | Directly | 8,764,232 | $27.17 | $238M | 99.3% | Form 4, Oct 24, 2023 |
| Arcutis Biotherapeutics ARQT Common Stock | Through The Heron Living Trust 11/30/2004 | 23,688 | $27.17 | $644K | 0.3% | Form 4, Oct 24, 2023 |
| Arcutis Biotherapeutics ARQT Common Stock | Through Topper Family Revocable Trust | 19,381 | $27.17 | $527K | 0.2% | Form 4, Oct 24, 2023 |
| Arcutis Biotherapeutics ARQT Common Stock | Through Topper Group II LLC | 11,266 | $27.17 | $306K | 0.1% | Form 4, Oct 24, 2023 |
| Arcutis Biotherapeutics ARQT Common Stock | Through Patrick J. Heron | 8,687 | $27.17 | $236K | 0.1% | Form 4, Oct 24, 2023 |
Share counts are the amounts Frazier Life Sciences VIII, L.P. reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Reported but not counted
These shares appear on Frazier Life Sciences VIII, L.P.'s filings but are held for charities, by investment funds the insider manages, or could not be valued reliably. Insiders usually disclaim ownership of fund holdings beyond their personal stake.
| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics ARQT Common Stock | FHM Life Sciences VIII, L.L.C. Held by a company or fund the insider manages | 7 | $27.17 | $190 | — | Form 4, Oct 24, 2023 |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 419 | Section 32 Fund 1, LP 10% owner, Dave | $244M |
| 420 | Fhmls X, L.P. 10% owner, MBX Biosciences | $243M |
| 421 | Third Rock Ventures GP VI, L.P. 10% owner, Septerna | $242M |
| 422 | Frazier Life Sciences VIII, L.P. 10% owner, Arcutis Biotherapeutics | $240M |
| 423 | Charles F. Dolan 2009 Family Trust Fbo Deborah A. Dolan-sweeney Insider, MSG Knickerbockers | $239M |
| 424 | Fhm Life Sciences Viii, L.P. 10% owner, Arcutis Biotherapeutics | $237M |
| 425 | ICONIQ Strategic Partners VI, L.P. 10% owner, Procore Technologies | $237M |
Other Arcutis Biotherapeutics insiders
All ARQT insiders- Bhaskar Chaudhuri$24.9MDirector. #4261 overall
- Todd Watanabe$21.1MSee Remarks. #4986 overall
- David W. Osborne$7.3MChief Technical Officer. #11068 overall
- Christopher Peetz$5.2MDirector. #2841 overall
- David Topper$5.0MChief Financial Officer. #14477 overall
- Larry Todd Edwards$4.8MSee Remarks. #6612 overall
Questions
How much stock does Frazier Life Sciences VIII, L.P. own?
Frazier Life Sciences VIII, L.P. holds $239,836,491 in listed stock based on SEC filings and current prices, mostly Arcutis Biotherapeutics (ARQT). That ranks 422nd on the Stock Rich List.
Is this Frazier Life Sciences VIII, L.P.'s net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
Files jointly with SEC filer 1341382, SEC filer 1365617.